Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02631733
Title Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Recruitment Suspended
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)

lung non-small cell carcinoma

stomach cancer

ovarian cancer

cervical cancer

neuroendocrine tumor

triple-receptor negative breast cancer

lung small cell carcinoma


Irinotecan + Veliparib

Age Groups: adult
Covered Countries USA

No variant requirements are available.